Know Labs Soars 14.57% on Bitcoin-Funded Acquisition

Know Labs (NYSE: KNW) has surged 14.57% in pre-market trading on June 11, 2025, driven by a significant acquisition of its parent company, primarily funded through Bitcoin (BTC).

The acquisition involves Goldeneye 1995 LLC, an investment vehicle tied to Greg Kidd, former chief risk officer at Ripple. Goldeneye is acquiring a controlling stake in Know Labs using 1,000 Bitcoin and additional cash. This move has sparked a rally in Know Labs' stock, which has seen a substantial increase in value over the past week.

Under the terms of the deal, Goldeneye will purchase common stock by dividing the total value of the 1,000 Bitcoin by Know Labs’ share price at the time of the agreement. This structure significantly increases Goldeneye’s equity stake in the company. Know Labs plans to retain Bitcoin as part of its treasury reserves, exposing investors to the digital currency.

Once the acquisition is finalized, Kidd will take over as CEO and also assume the role of chairman of the board. Kidd expressed his enthusiasm for deploying a Bitcoin treasury strategy, believing it will generate sustainable growth and long-term shareholder value.

Know Labs specializes in noninvasive health monitoring technology. Its flagship product in development, KnowU, is a wearable, continuous glucose monitor designed to help people with diabetes manage their blood sugar without needles. The device offers a discreet and convenient alternative to traditional glucose testing, which can be worn on the wrist, forearm, or as an adhesive patch with a removable sensor.